The U.S. Food and Drug Administration (FDA) is alerting healthcare professionals and patients of a voluntary recall of all unexpired albuterol sulfate inhalation aerosol manufactured by Catalent Pharma Solutions for Perrigo Pharmaceutical Company. This recall is to the retail level and is due to complaints that some units may not dispense due to clogging.

The FDA is advising patients to:

  • immediately seek emergency care if needed;
  • use their Perrigo inhaler they have on hand, as needed and as directed by a doctor;
  • have extra inhalers or an alternative treatment available in case of malfunction, as some of these recalled inhalers stop working after several uses; and
  • contact their healthcare professional or pharmacist with questions.

Read the FDA Announcement